NeuroPace
NPCE
NeuroPace (NPCE) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jul 29, 2026 |
| Mizuho | Initiated Coverage | Outperform | $22.00 | Jul 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $19.00 | May 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $19.00 from $18.00 | Jan 27, 2026 |
| UBS | Maintained | Buy | $22.00 from $18.00 | Dec 16, 2025 |
| JP Morgan | Maintained | Overweight | $20.00 from $18.00 | Dec 10, 2025 |
| JP Morgan | Maintained | Overweight | $18.00 from $16.00 | Nov 5, 2025 |
| Wells Fargo | Maintained | Overweight | $16.00 from $15.00 | Nov 5, 2025 |
| Wells Fargo | Maintained | Overweight | $15.00 from $17.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $18.00 | May 28, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $17.00 | May 14, 2025 |
| JP Morgan | Maintained | Overweight | $16.00 from $14.00 | May 14, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $20.00 from $19.00 | Mar 5, 2025 |
| Wells Fargo | Maintained | Overweight | $17.00 from $13.00 | Jan 30, 2025 |
| UBS | Initiated Coverage | Buy | $17.00 | Jan 21, 2025 |
| JP Morgan | Maintained | Overweight | $14.00 from $9.00 | Dec 17, 2024 |
| Wells Fargo | Maintained | Overweight | $13.00 from $15.00 | Nov 13, 2024 |
| Wells Fargo | Maintained | Overweight | $15.00 from $20.00 | Aug 14, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | $18.00 | Aug 14, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $8.00 from $9.50 | Jul 15, 2024 |
Frequently asked questions
What is the latest analyst rating on NPCE?
On Jul 29, 2026, HC Wainwright & Co. maintained NeuroPace at Buy with a price target of $20.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.